A Study to Learn About the Benefit of Rimegepant Versus Triptans in Migraine Buddy App Users.
Clinical trial NCT06532357 · COMPLETED
Trial details
- NCT number
- NCT06532357
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-06-09
- Primary completion
- 2024-06-10
- Enrollment
- 1536
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.